Repligen Corporation (NASDAQ:RGEN)’s traded shares stood at 280,429 during the last session, with the company’s beta value hitting 0.84. At the close of trading, the stock’s price was $177.79, to imply an increase of 1.25% or $2.19 in intraday trading. The RGEN share’s 52-week high remains $228.84, putting it -28.71% down since that peak but still an impressive +38.48% since price per share fell to its 52-week low of $109.38. The company has a valuation of $9.76 Billion, with an average of 414.65 Million shares in intraday trading volume over the past 10 days and average of 425.99 Million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Repligen Corporation (RGEN), translating to a mean rating of 1.7. Of 9 analyst(s) looking at the stock, none analyst(s) give RGEN a Sell rating. None of those analysts rate the stock as Overweight while 1 advise Hold as 8 recommend it as a Buy. None analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.52.
After registering a 1.25% upside in the last session, Repligen Corporation (RGEN) has traded red over the past five days. The stock hit a weekly high of $187.2 this Friday, May 28, jumping 5.03% in its intraday price action. The 5-day price performance for the stock is -2.02%, and -8.67% over 30 days. Despite these dips, the year-to-date price performance is -7.22%. Short interest in Repligen Corporation (NASDAQ:RGEN) saw shorts transact 1.62 Million shares and set a 0 days time to cover.
Analysts on Wall Street suggest a consensus price target of $240.25, implying an increase of 35.13% to the stock’s current value. The extremes give us $200 and $251 for target low and target high price respectively. As such, RGEN has been trading 41.18% off suggested target high and 12.49% from its likely low.
Repligen Corporation (RGEN) estimates and forecasts
Looking at statistics comparing Repligen Corporation share performance against respective industry, we note that the company has outperformed competitors. Repligen Corporation (RGEN) shares are -4.93% down over the last 6 months, with its year-to-date growth rate higher than industry average at 33.94% against 9%. But the analysts are intensifying their growth estimates for the 2021 fiscal year. Revenue is forecast to grow 23.8% this quarter before jumping 30% for the next one. The rating firms project that company’s revenue will grow 59.9% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is $144.1 Million. Meanwhile, for the quarter ending September 01, 2021, a total of 9 analyst(s) estimate revenue growth to $145.92 Million. Earnings reports from the last fiscal year show that sales brought in $87.46 Million and $86.45 Million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 64.8% before jumping 68.8% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 31.9% for the past 5-year period. While 2021 is set for a 155.5% return in earnings, projections for the next 5 years are at 31.5% annually.
Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.
Add them to your watchlist before they take off!
Repligen Corporation (NASDAQ:RGEN)’s Major holders
Repligen Corporation insiders hold 6.96% of total outstanding shares, with institutional holders owning 85.02% of the shares at 91.39% float percentage. In total, 616 institutions holds shares in the company, led by Blackrock Inc. As of Dec 30, 2020, the company held over 4.53 Million shares (or 8.26% of shares), all amounting to roughly $868.56 Million.
The next major institution holding the largest number of shares is Vanguard Group, Inc. (The) with 4.41 Million shares, or about 8.03% of shares outstanding. As of the market price on Dec 30, 2020, these shares were worth $845.23 Million.
We also have iShares Core S&P Midcap ETF and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Repligen Corporation (RGEN) shares. Going by data provided on Mar 30, 2021, iShares Core S&P Midcap ETF holds roughly 1,375,410 shares. This is just over 2.51% of the total shares, with a market valuation of $267.39 Million. Data from the same date shows that the other fund manager holds a little less at 1.33 Million, or 2.43% of the shares, all valued at about $255.67 Million.